These results implicated that Lr263 may improve insulin resistance, enhance glycemic control, and maintain glucose homeostasis in adipose tissue through upregulation of PPAR-γ and GLUT4 expressions. The gene discussed is SLC2A4; the disease is Insulin resistance.